Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00140842 · ClinicalTrials.gov registry record
Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 47
- Enrollment target
NCT00140842: Completed study, sponsored by Massachusetts General Hospital.
NCT00140842 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00140842 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
This study will examine hormonal differences in ghrelin and growth hormone in obese and normal weight adolescents and their relationship to body composition and insulin resistance. The study will also investigate the effect of the macronutrient composition of a meal on postprandial ghrelin levels and whether ghrelin responses will predict the degree of hunger and caloric intake at a subsequent meal.
Primary Outcome
Peak growth hormone (GH) on the GH stimulation test is a measure of the adequacy of GH secretion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2005-05 |
| Est. Completion | 2007-06 |
What the finished NCT00140842 record still lists
NCT00140842 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00140842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00140842 about?
NCT00140842 is a clinical study titled "Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents". This study will examine hormonal differences in ghrelin and growth hormone in obese and normal weight adolescents and their relationship to body composition and insulin resistance. The study will also investigate the effect of the macronutrient composition of a meal on postprandial ghrelin levels an...
What is the current status of trial NCT00140842?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2005-05. Estimated completion is 2007-06.
Who is sponsoring clinical trial NCT00140842?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia